Cytosorbents Corp. Withdraws Prior Financial Statements
Ticker: CTSO · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: financial-restatement, accounting-issues, disclosure
TL;DR
Cytosorbents is ditching old financials - big red flag for investors.
AI Summary
Cytosorbents Corporation announced on March 25, 2025, that it will not rely on previously issued financial statements. This decision impacts financial reporting and may require restatements, affecting investor confidence and potentially future financial performance.
Why It Matters
This filing indicates potential issues with Cytosorbents' past financial reporting, which could lead to restatements and impact investor trust.
Risk Assessment
Risk Level: high — Non-reliance on previously issued financial statements suggests significant accounting or reporting issues that could materially impact the company's financial position.
Key Players & Entities
- Cytosorbents Corporation (company) — Registrant
- March 25, 2025 (date) — Date of Earliest Event Reported
- 305 College Road East Princeton, New Jersey 08540 (address) — Principal executive offices
FAQ
What specific financial statements are affected by this non-reliance announcement?
The filing states that the company will not rely on 'previously issued financial statements,' implying all prior statements are under review.
What is the primary reason for Cytosorbents Corporation's decision to not rely on previously issued financial statements?
The filing does not specify the exact reason but indicates a need to reassess past financial reporting.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on March 25, 2025.
What is the company's principal executive office address?
The principal executive offices are located at 305 College Road East, Princeton, New Jersey 08540.
What is the filing date of this 8-K report?
This 8-K report was filed as of March 31, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding Cytosorbents Corp (CTSO).